IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial, page-21

  1. 392 Posts.
    lightbulb Created with Sketch. 47
    Nice to see it gaining momentum. Not the most reputable publication, but large audience
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.001(1.43%)
Mkt cap ! $5.335M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $2.546K 35.86K

Buyers (Bids)

No. Vol. Price($)
1 14158 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 14.37pm 31/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.